Concepedia

Jennifer Haig

JH

5

Publications

107

Citations

5

H-Index

2012

Active since

Affiliations

Novartis (Switzerland)(Current)

University of York

Novartis (United Kingdom)

Jennifer Haig is an author at Novartis (Switzerland) specializing in oncology, radiation oncology, and cancer research.

Top concepts

Publications per year

2012–2016

5

Publications

5

A Comparative Analysis of Two Contrasting European Approaches for Rewarding the Value Added by Drugs for Cancer: England Versus France

Michael Drummond, Gérard de Pouvourville, Elizabeth C. Jones et al. · PharmacoEconomics · 2014 · 36 citations

, , +13

Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective

Stéphane A. Régnier, William Malcolm, Jennifer Haig et al. · ClinicoEconomics and Outcomes Research · 2015 · 28 citations · Full text

Ranibizumab, Verteporfin Photodynamic Therapy or Observation for the Treatment of Myopic Choroidal Neovascularization: Cost Effectiveness in the UK

Lindsay Claxton, Bill Malcolm, Matthew Taylor et al. · Drugs & Aging · 2014 · 15 citations · Full text

Cost-effectiveness of ranibizumab in the treatment of visual impairment due to diabetic macular edema

Jennifer Haig, M Barbeau, Alberto Ferreira · Journal of Medical Economics · 2016 · 15 citations

Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada

Michele Kohli, Donna Lawrence, Jennifer Haig et al. · BMC Public Health · 2012 · 13 citations · Full text

Rows per page

1–5 of 5